M. Toft-Nielsen - Concepedia

Author

M. Toft-Nielsen

Also Known As

H. Chapman, L. Sard, M B Toft-Nielsen, M Toft-Nielsen, M. B. Toft-Nielsen, M. Toft-Nielsen, M.-B. Toft-Nielsen, Mai-Britt Toft-Nielsen

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

University of Copenhagen Hvidovre Hospital

About

M. Toft-Nielsen is an author at University of Copenhagen specializing in medicine, biochemistry, and endocrinology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	847
2	Biochemistry	2	2	847
3	Diabetes	1	1	716
4	Endocrinology	1	1	131
5	Pharmacology	1	1	716

M. Toft-Nielsen

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Determinants of the Impaired Secretion of Glucagon-Like Peptide-1 in Type 2 Diabetic Patients M. Toft-Nielsen, Mette Brimnes Damholt, Sten Madsbad, The Journal of Clinical Endocrinology & Metabolism	2001	835
Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects Carolyn F. Deacon, Michael A. Nauck, M. Toft-Nielsen, Diabetes Diabetes ManagementHealthy SubjectsBiochemistryMedicineInsulin Management	1995	716
Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients. M. Toft-Nielsen, Sten Madsbad, Jens J. Holst Diabetes Care	1999	334
Determinants of the Impaired Secretion of Glucagon-Like Peptide-1 in Type 2 Diabetic Patients M. Toft-Nielsen The Journal of Clinical Endocrinology & Metabolism	2001	172
Determinants of the Effectiveness of Glucagon-Like Peptide-1 in Type 2 Diabetes M. Toft-Nielsen, Sten Madsbad, Jens J. Holst The Journal of Clinical Endocrinology & Metabolism	2001	159
Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia M. Toft-Nielsen, Sten Madsbad, Jens J. Holst Diabetologia Exaggerated SecretionBiochemistryG Protein-coupled ReceptorPhysiologyHypoxia (Medicine)	1998	131
Additive Glucose-Lowering Effects of Glucagon-Like Peptide-1 and Metformin in Type 2 Diabetes Mette Zander, Mustafa Taskiran, M. Toft-Nielsen, Diabetes Care	2001	62
Evaluation of beta-cell secretory capacity using glucagon-like peptide 1. Tina Vilsbøll, M. Toft-Nielsen, Thure Krarup, Diabetes Care	2000	37
Nutrient re-routing and altered gut-islet cell crosstalk may explain early relief of severe postprandial hypoglycaemia after reversal of Roux-en-Y gastric bypass Maria S. Svane, M. Toft-Nielsen, Viggo B. Kristiansen, Diabetic Medicine	2017	12

Page 1